An Inhibitor of Human Asparagine Synthetase Suppresses Proliferation of an L-Asparaginase-Resistant Leukemia Cell Line

Chemistry and Biology

Volumn 13, Issue 12, 2006, Pages 1339-1347

  Gutierrez, Jemy A ^a   Pan, Yuan Xiang ^b   Koroniak, Lukasz ^a   Hiratake, Jun ^c   Kilberg, Michael S ^b,d   Richards, Nigel G J ^a,d  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

CELLCYCLE; CHEMBIOL

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; ASPARTATE AMMONIA LIGASE; ENZYME INHIBITOR; SULFUR AMINO ACID;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AMINO ACIDS, SULFUR; ANTINEOPLASTIC AGENTS; ASPARAGINASE; ASPARTATE-AMMONIA LIGASE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MODELS, MOLECULAR; MOLECULAR STRUCTURE;

EID: 33845591794     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2006.10.010     Document Type: Article

References (70)

1. Aghaiypour K., Wlodawer A., and Lubkowski J. Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase. Biochemistry 40 (2001) 5655-5664
2. Barr R.D., DeVeber L.L., Pai K.M., Andrew M., Halton J., Cairney A.E., and Whitton A.C. Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocol. Am. J. Pediatr. Hematol. Oncol. 14 (1992) 136-139
3. Ertel I.J., Nesbit M.G., Hammon D., Weiner J., and Sather H. Effective dose of L-asparaginase for induction of remission in previously untreated children with acute lymphocytic leukemia: a report from the childrens cancer study group. Cancer Res. 39 (1979) 3893-3896
4. Sutow W.W., Garacia F., Starling K.A., Williams T.E., Lane D.M., and Gehan E.A. L-asparaginase therapy in children with advanced leukemia. Cancer 28 (1971) 819-824
5. Richards N.G.J., and Schuster S.M. Mechanistic issues in asparagine synthetase catalysis. Adv. Enzymol. Relat. Areas Mol. Biol. 72 (1998) 145-198
6. Richards N.G.J., and Kilberg M.S. Asparagine synthetase chemotherapy. Annu. Rev. Biochem. 75 (2006) 629-654
7. Aslanian A.M., and Kilberg M.S. Asparagine synthetase expression alone is sufficient to induce L-asparaginase resistance in MOLT-4 human leukemia cells. Biochem. J. 357 (2001) 321-328
8. Kiriyama Y., Kubota M., Takimoto T., Kitoh J., Tanizawa A., Akiyama Y., and Mikawa H. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase. Leukemia 3 (1989) 294-297
9. Chakrabarti R., and Schuster S.M. L-asparaginase: perspectives on the mechanisms of action and resistance. J. Pediatr. Hematol. Oncol. 4 (1997) 597-611
10. Haskell C.M., and Canellos G.P. L-asparaginase resistance in human leukemia-asparagine synthetase. Biochem. Pharmacol. 18 (1969) 2578-2580
11. Graham M.L. Pegaspargase: a review of clinical studies. Adv. Drug Deliv. Rev. 55 (2003) 1293-1302
12. Cooney D.A., and Handschumacher R.E. L-asparaginase and L-asparagine metabolism. Annu. Rev. Pharmacol. 10 (1970) 421-440
13. Appel I.M., den Boer M.L., Meijerink J.P.P., Veerman A.J.P., Reniers N.C.M., and Pieters R. Up-regulation of asparagine synthetase expression is not linked to the clinical response to L-asparaginase in pediatric acute lymphoblastic leukemia. Blood 106 (2006) 4244-4249
14. Fine B.M., Kaspers G.J., Ho M., Loonen A.H., and Boxer L.M. A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia. Cancer Res. 65 (2005) 291-299
15. Stams W.A.G., den Boer M.L., Holleman A., Appel I.M., Beverloo H.B., van Wering E.R., Janka-Schaub G.E., Evans W.E., and Pieters R. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. Blood 105 (2005) 4223-4225
16. Jayaram H.N., and Cooney D.A. Analogs of L-aspartic acid in chemotherapy for cancer. Cancer Treat. Rep. 63 (1979) 1095-1108
17. Cooney D.A., Driscoll J.S., Milman H.A., Jayaram H.N., and Davis R.D. Inhibitors of L-asparagine synthetase in vitro. Cancer Treat. Rep. 60 (1976) 1493-1557
18. Larsen T.M., Boehlein S.K., Schuster S.M., Richards N.G.J., Thoden J.B., Holden H.M., and Rayment I. Three-dimensional structure of Escherichia coli asparagine synthetase B: a short journey from substrate to product. Biochemistry 38 (1999) 16146-16157
19. Boehlein S.K., Stewart J.D., Walworth E.S., Thirumoorthy R., Richards N.G.J., and Schuster S.M. Kinetic mechanism of Escherichia coli asparagine synthetase B. Biochemistry 37 (1998) 13230-13238
20. Luehr C.A., and Schuster S.M. Purification and characterization of beef pancreatic asparagine synthetase. Arch. Biochem. Biophys. 237 (1985) 335-346
21. Huang X., Holden H.M., and Raushel F. Channeling of substrates and intermediates in enzyme-catalyzed reactions. Annu. Rev. Biochem. 70 (2001) 149-180
22. Tesson A.R., Soper T.S., Ciustea M., and Richards N.G.J. Revisiting the steady-state kinetic mechanism of glutamine-dependent asparagine synthetase from Escherichia coli. Arch. Biochem. Biophys. 413 (2003) 23-31
23. Koroniak L., Ciustea M., Gutierrez J.A., and Richards N.G.J. Synthesis and characterization of an N-acylsulfonamide inhibitor of human asparagine synthetase. Org. Lett. 5 (2003) 2033-2036
24. Koizumi M., Hiratake J., Nakatsu T., Kato H., and Oda J. A potent transition-state analogue inhibitor of Escherichia coli asparagine synthetase A. J. Am. Chem. Soc. 121 (1999) 5799-5800
25. Srivasta B.I., and Minowada J. Terminal deoxynucleotidyl transferase-activity in a cell line (MOLT-4) derived from peripheral blood of a patient with acute lymphoblastic leukemia. Biochem. Biophys. Res. Commun. 51 (1973) 529-535
26. Cedar H., and Schwartz J.H. The asparagine synthetase of Escherichia coli I: biosynthetic role of the enzyme, purification and characterization of the reaction products. J. Biol. Chem. 244 (1969) 4112-4121
27. Nakatsu T., Kato H., and Oda J. Crystal structure of asparagine synthetase reveals a close evolutionary relationship to class II aminoacyl tRNA synthetase. Nat. Struct. Biol. 5 (1998) 15-19
28. Cramer C.J. Essentials of Computational Chemistry (2002), Wiley, New York pp. 121-151
29. Stewart J.J.P. Optimization of parameters for semiempirical methods I: method. J. Comput. Chem. 10 (1989) 209-220
30. Klamt A. Conductor-like screening model for real solvents: a new approach to the quantitative calculation of solvation phenomena. J. Phys. Chem. 99 (1995) 2224-2235
31. Cramer C.J., and Truhlar D.G. Implicit solvation models: equilibria, structure, spectra, and dynamics. Chem. Rev. 99 (1999) 2161-2200
32. Ciustea M., Gutierrez J.A., Abbatiello S.E., Eyler J.R., and Richards N.G.J. Efficient expression, purification and characterization of C-terminally tagged, recombinant human asparagine synthetase. Arch. Biochem. Biophys. 440 (2005) 18-27
33. O'Brien W.E. A continuous spectrophotometric assay for argininosuccinate synthetase based on pyrophosphate formation. Anal. Biochem. 76 (1976) 423-430
34. Horowitz B., and Meister A. Glutamine-dependent asparagine synthetase from leukemia cells. J. Biol. Chem. 247 (1972) 6708-6719
35. Boehlein S.K., Nakatsu T., Hiratake J., Thirumoorthy R., Stewart J.D., Richards N.G.J., and Schuster S.M. Characterization of inhibitors acting at the synthetase site of Escherichia coli asparagine synthetase B. Biochemistry 40 (2001) 11168-11175
36. Morrison J.F., and Walsh C.T. The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61 (1988) 201-301
37. Tokutake N., Hiratake J., Katoh M., Irie T., Kato H., and Oda J. Design, synthesis and evaluation of transition-state analogue inhibitors of Escherichia coli γ-glutamylcysteine synthetase. Bioorg. Med. Chem. 6 (1998) 1935-1953
38. Manning J.M., Moore S., Rowe W.B., and Meister A. Identification of L-methionine S-sulfoximine as the diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase. Biochemistry 8 (1969) 2681-2685
39. Campbell E.B., Hayward M.L., and Griffith O.W. Analytical and preparative separation of the diastereoisomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis. Anal. Biochem. 194 (1991) 268-277
40. Wilmouth R.C., Edman K., Neutze R., Wright P.A., Clifton I.J., Schneider T.R., Schofield C.J., and Hadju J. X-ray snapshots of serine protease catalysis reveals a tetrahedral intermediate. Nat. Struct. Biol. 8 (2001) 689-694
41. Weiss P.M., and Cleland W.W. Effect of the presence of a reversible inhibitor on the time course of slow-binding inhibition. Anal. Biochem. 161 (1987) 438-441
42. Cha S. Tight-binding inhibitors. I: kinetics. Biochem. Pharmacol. 24 (1975) 2177-2185
43. Logusch E.W., Walker D.M., McDonald J.F., Franz J.E., Villafranca J.J., DiIanni C.L., Colanduoni J.A., Li B., and Schineller J.B. Inhibition of Escherichia coli glutamine synthetase by α-substituted and γ-substituted phosphinothricins. Biochemistry 29 (1990) 366-372
44. Abell L.M., and Villafranca J.J. Investigation of the mechanism of phosphinothricin inactivation of Escherichia coli glutamine synthetase using rapid quench techniques. Biochemistry 30 (1991) 6135-6141
45. Liaw S.H., and Eisenberg D. Structural model for the reaction mechanism of glutamine synthetase, based on 5 crystal structures of enzyme-substrate complexes. Biochemistry 33 (1994) 675-681
46. Manning J.M., Moore S., Rowe W.B., and Meister A. Identification of L-methionine S-sulfoximine as diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase. Biochemistry 8 (1969) 2681-2685
47. Weisbrod R.E., and Meister A. Studies on glutamine synthetase from Escherichia coli: formation of pyrrolidone carboxylate and inhibtion by methionine sulfoximine. J. Biol. Chem. 248 (1973) 3997-4002
48. Schnizer H.G., Boehlein S.K., Stewart J.D., Schuster S.M., and Richards N.G.J. The γ-glutamyl thioester covalent intermediate in the glutaminase reaction catalyzed by Escherichia coli asparagine synthetase B. Methods Enzymol. 354 (2002) 260-271
49. Schnizer H.G., Boehlein S.K., Stewart J.D., Richards N.G.J., and Schuster S.M. Formation and isolation of a covalent intermediate during the glutaminase reaction of a class II amidotransferase. Biochemistry 38 (1999) 3677-3682
50. Bernt E., and Bergmeyer H.U. L-Glutamate UV assay with glutamate dehydrogenase and NAD. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Academic Press, New York 1704-1708
51. Boehlein S.K., Richards N.G.J., and Schuster S.M. Glutamine-dependent nitrogen transfer in Escherichia coli asparagine synthetase B: searching for the catalytic triad. J. Biol. Chem. 269 (1994) 7450-7457
52. Boehlein S.K., Richards N.G.J., and Schuster S.M. Arginine 30 and asparagine 74 have functional roles in the glutamine dependent activities of Escherichia coli asparagine synthetase B. J. Biol. Chem. 269 (1994) 26789-26795
53. Zalkin H., and Smith J.L. Enzymes using glutamine as an amide donor. Adv. Enzymol. Relat. Areas Mol. Biol. 72 (1998) 87-144
54. Zalkin H. The amidotransferases. Adv. Enzymol. Relat. Areas Mol. Biol. 66 (1993) 203-309
55. Bera A.K., Smith J.L., and Zalkin H. Dual role for the glutamine phosphoribosyl-phosphate amidotransferase ammonia channel: interdomain signaling and intermediate channeling. J. Biol. Chem. 275 (2000) 7975-7979
56. Badet-Denisot M.A., René L., and Badet B. Mechanistic investigations on glucosamine-6-phosphate synthase. Bull. Soc. Chim. Fr. 130 (1993) 249-255
57. Hutson R.G., Kitoh T., Moraga-Amador D., Cosic S., Schuster S.M., and Kilberg M.S. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. Am. J. Physiol. 272 (1997) C1691-C1699
58. Aslanian A.M., and Kilberg M.S. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukemia cells. Biochem. J. 357 (2001) 58-67
59. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., and Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull. 19 (1996) 1518-1520
60. Leslie M., Case M.C., Hall A.G., and Coulthard S.A. Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukemia. Br. J. Haematol. 132 (2006) 740-742
61. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23 (1997) 3-25
62. Butcher R.A., and Schreiber S.L. Using genome-wide transcriptional profiling to elucidate small molecule mechanisms. Curr. Opin. Chem. Biol. 9 (2005) 25-30
63. Smukste I., and Stockwell B.R. Advances in chemical genetics. Annu. Rev. Genomics Hum. Genet. 6 (2005) 261-286
64. Bradford M.M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
65. Thompson J.S., and Edmonds O.P. Safety aspects of handling the potent allergen FDNB. Ann. Occup. Hyg. 23 (1980) 27-33
66. Orth D.L. HPLC determination of taurine in sports drinks. J. Chem. Educ. 78 (2001) 791-792
67. Morton R.C., and Gerber G.E. Amino acid analysis by dinitrophenylation and reverse-phase high-pressure liquid chromatography. Anal. Biochem. 170 (1988) 220-227
68. Cleland W.W. Statistical analysis of enzyme kinetic data. Methods Enzymol. 63 (1979) 103-138
69. Stewart J.J.P. MOPAC: a semiempirical molecular orbital program. J. Comput. Aided Mol. Des. 4 (1990) 1-45
70. Purvis III G.D. On the use of isovalued surfaces to determine molecular shape and reaction pathways. J. Comput. Aided Mol. Des. 5 (1991) 55-80